author-photo

Lenora Davis

Merck & Co.

19

Papers

2697

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival

2014 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (32)
Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer.

2011 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (48)
Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis

2010 American Journal of Pathology
Show All
- Source
- Cite
- Save
Citations (139)
MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (70)
FGFR2-Amplified Gastric Cancer Cell Lines Require FGFR2 and Erbb3 Signaling for Growth and Survival

2008 Cancer Research
Show All
- Source
- Cite
- Save
Citations (213)
Novel Flt-3/KDR inhibitor is effective against activated Flt-3 and is cytotoxic against Flt-3-driven leukemias in vitro and in vivo

2004 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A novel orally bioavailable inhibitor of kinase insert domain-containing receptor induces antiangiogenic effects and prevents tumor growth in vivo.

2004 Cancer Research
Show All
- Source
- Cite
- Save
Citations (23)
Identification of amino acid residues required for Ras p21 target activation.

1991 Molecular and Cellular Biology
Show All
- Source
- Cite
- Save
Citations (53)
Expression of active human immunodeficiency virus type 1 protease by noninfectious chimeric virus particles.

1991 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (14)
Characterization of an active single polypeptide form of the human immunodeficiency virus type 1 protease.

1990 Journal of Biological Chemistry
Show All
- Source
- Cite
- Save
Citations (61)